Phase 2 study

ATL: Results of a Multi-Institutional Phase 2 Study (JGOG1066)
Takafumi Toita, Ryo Kitagawa, Tetsutaro Hamano, Kenji Umayahara, Yasuyuki Hirashima, Yoichi Aoki, Masahiko Oguchi, Mikio Mikami, Ken Takizawa

International Journal of Gynecologic Cancer Oct 2012, 22 (8) 1420-1426; DOI: 10.1097/IGC.0b013e3182647265
A Phase 2 Multicenter Study of Irinotecan and Cisplatinum as Neoadjuvant Treatment in Patients With Locally Advanced Cervical Cancer
Francesco Raspagliesi, Antonino Ditto, Luigi Selvaggi, Luigi Frigerio, Mauro Melpignano, Giovanni Scambia, Chiara Apolloni, Paolo Scollo, Sandro Pignata, Pierluigi Benedetti Panici

International Journal of Gynecologic Cancer Nov 2010, 20 (9) 1569-1575; DOI: 10.1111/IGC.0b013e3181cc71f7
A Phase 2 study of cisplatin analog CI-973 in the treatment of patients with refractory, advanced ovarian cancer
J.A. Roberts, A. P. Kudelka, D. R. Spriggs, F. Muggia, J. Lurain, W. Grove, C. Kowal

International Journal of Gynecologic Cancer Jul 1996, 6 (4) 257-260; DOI: 10.1136/ijgc-00009577-199607000-00002

Main menu